Multidisciplinary care in the management of childhood cancer

C R Pinkerton1

  • 1Royal Marsden Hospital, Sutton, Surrey.

Insights

Curing childhood cancer with minimal harm is a key goal. This review examines multidisciplinary supportive care for effective high-dose chemotherapy in pediatric oncology patients.

Area of Science:

  • Pediatric Oncology
  • Clinical Medicine
  • Cancer Treatment

Background:

  • Minimizing short- and long-term morbidity is crucial in pediatric cancer care.
  • High-dose chemotherapy offers effective cancer treatment but necessitates comprehensive supportive care.
  • Coordinated care across disciplines is essential for managing pediatric cancer patients.

Purpose of the Study:

  • To review the interactions among healthcare teams involved in pediatric cancer patient care.
  • To highlight the importance of supportive care in optimizing high-dose chemotherapy outcomes.
  • To address challenges in achieving cure with minimal morbidity in children with cancer.

Main Methods:

  • Literature review focusing on multidisciplinary supportive care in pediatric oncology.
  • Analysis of patient care pathways from early diagnosis through long-term follow-up.
  • Examination of interdisciplinary collaboration in managing treatment toxicity.

Main Results:

  • Effective high-dose chemotherapy requires integrated supportive care.
  • Interactions between various medical disciplines impact patient outcomes.
  • Addressing both acute and chronic toxicities is vital for long-term patient well-being.

Conclusions:

  • Optimizing pediatric cancer cure necessitates a collaborative, multidisciplinary approach to supportive care.
  • Seamless coordination between early and late care teams improves outcomes and reduces morbidity.
  • Further research into interdisciplinary models can enhance the management of childhood cancers.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...